Insider Trading Activity Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Director Sold 1,240,000 shares of Stock

Insider Trading Activity For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Reeve B. Waud , Director of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reportedly Sold 1,240,000 shares of the company’s stock at an average price of 51.72 for a total transaction amount of $64,132,800.00 SEC Form

Insider Trading History For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

On 12/24/2012 Ronald Morgan Fincher, COO, sold 8,909 with an average share price of $21.60 per share and the total transaction amounting to $192,434.40.View SEC Filing

On 12/24/2012 Reeve B Waud, Director, sold 425,591 with an average share price of $21.60 per share and the total transaction amounting to $9,192,765.60.View SEC Filing

On 12/24/2012 Joey A Jacobs, CEO, sold 39,927 with an average share price of $21.60 per share and the total transaction amounting to $862,423.20.View SEC Filing

On 12/24/2012 Christopher L Howard, EVP, sold 8,774 with an average share price of $21.60 per share and the total transaction amounting to $189,518.40.View SEC Filing

On 12/24/2012 Bruce A Shear, Chairman, sold 7,500 with an average share price of $21.60 per share and the total transaction amounting to $162,000.00.View SEC Filing

On 12/24/2012 Brent Turner, Major Shareholder, sold 10,551 with an average share price of $21.60 per share and the total transaction amounting to $227,901.60.View SEC Filing

On 5/7/2013 Ronald Morgan Fincher, COO, sold 2,804 with an average share price of $32.78 per share and the total transaction amounting to $91,915.12.View SEC Filing

Analyst Ratings For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
These are 3 Hold Ratings, 9 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is Buy (Score: 2.85) with a consensus target price of $59.67 , a potential (14.55% upside)

Analyst Ratings History For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

• On 2/17/2016 Avondale Partners Lower Price Target of rating Market Outperform with a price target of $90.00 to $71.00
• On 2/18/2016 Susquehanna Bancshares Inc Lower Price Target of rating Positive with a price target of $92.00 to $75.00
• On 2/20/2016 Stephens Reiterated Rating Buy
• On 9/15/2016 Robert W. Baird Lower Price Target of rating Outperform with a price target of $67.00 to $66.00
• On 9/27/2016 J P Morgan Chase & Co Reiterated Rating Hold with a price target of $61.00
• On 11/3/2016 Raymond James Financial, Inc. Upgraded rating Outperform to Strong-Buy with a price target of $65.00
• On 1/3/2017 Royal Bank Of Canada Reiterated Rating Buy with a price target of $56.00

Recent Trading Activity for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
Shares of Acadia Healthcare Company, Inc. closed the previous trading session at 52.09 down -0.84 -1.59% with 2,238,744 shares trading hands.